About LifeArc
LifeArc is a company based in London (United Kingdom) founded in 1992. It operates as a Professional Services and Donation / Grant-Based. LifeArc offers products and services including Antibody Development, Small Molecule Drug Discovery, and Diagnostics Development.
- Headquarter London, United Kingdom
-
Sectors
Financial Services
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Lifearc (Company No. 2698321)
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$388.75 K (USD), Grant
Apr 01, 2016
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of LifeArc
LifeArc offers a comprehensive portfolio of products and services, including Antibody Development, Small Molecule Drug Discovery, and Diagnostics Development.
Antibody humanisation services are provided for therapeutic development.
Small molecule drugs are developed for various diseases.
Diagnostic tools are created for disease detection purposes.
People of LifeArc
Unlock access to complete
Unlock access to complete
Funding Insights of LifeArc
Investments & Acquisitions by LifeArc
Investment portfolio details for LifeArc
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - LifeArc
Detailed financials for LifeArc
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Lifearc Comparisons
Peer comparison for LifeArc
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of LifeArc
Detailed competitors of LifeArc
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Lifearc
Complete news archive for LifeArc
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about LifeArc
LifeArc was founded in 1992 and raised its 1st funding round 24 years after it was founded.
LifeArc is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Melanie Lee is the current CEO of LifeArc.
LifeArc is engaged in translating promising scientific research into practical healthcare solutions. Activities are centered on drug discovery, antibody humanisation, diagnostics, and biomarker development. Sectors addressed include rare diseases, motor neuron disease, chronic respiratory conditions, childhood cancer, and global health challenges. Partnerships are formed to progress science towards commercial viability, while funding and investment are provided for early-stage ventures and open calls. Translational challenges are tackled by combining scientific expertise, advice, and collaborative efforts to deliver impactful patient outcomes.
LifeArc offers Antibody Development, Small Molecule Drug Discovery, and Diagnostics Development.